Aveo initiates Phase Ib/IIa breast cancer trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Year:
      2009
    • Subject Terms:
    • Subject Terms:
    • NAICS/Industry Codes:
      NAICS/Industry Codes 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
    • Abstract:
      The article reports that biotechnology company Aveo Pharmaceuticals Inc. has initiated a Phase lb/lla clinical trial in breast cancer in the U.S. It states that the trial is aimed at exploring the potential of combining AV-951 with leading targeted agents. Safety, tolerability and maximum tolerated dose (MTD) were the expected primary outcomes of the trial among 20 patients with progressive disease.
    • Accession Number:
      37326332
  • Citations
    • ABNT:
      Aveo initiates Phase Ib/IIa breast cancer trial. PharmaWatch: Cancer, [s. l.], v. 8, n. 4, p. 8, 2009. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332. Acesso em: 30 maio. 2020.
    • AMA:
      Aveo initiates Phase Ib/IIa breast cancer trial. PharmaWatch: Cancer. 2009;8(4):8. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332. Accessed May 30, 2020.
    • APA:
      Aveo initiates Phase Ib/IIa breast cancer trial. (2009). PharmaWatch: Cancer, 8(4), 8.
    • Chicago/Turabian: Author-Date:
      “Aveo Initiates Phase Ib/IIa Breast Cancer Trial.” 2009. PharmaWatch: Cancer 8 (4): 8. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332.
    • Harvard:
      ‘Aveo initiates Phase Ib/IIa breast cancer trial’ (2009) PharmaWatch: Cancer, 8(4), p. 8. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332 (Accessed: 30 May 2020).
    • Harvard: Australian:
      ‘Aveo initiates Phase Ib/IIa breast cancer trial’ 2009, PharmaWatch: Cancer, vol. 8, no. 4, p. 8, viewed 30 May 2020, .
    • MLA:
      “Aveo Initiates Phase Ib/IIa Breast Cancer Trial.” PharmaWatch: Cancer, vol. 8, no. 4, Apr. 2009, p. 8. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332.
    • Chicago/Turabian: Humanities:
      “Aveo Initiates Phase Ib/IIa Breast Cancer Trial.” PharmaWatch: Cancer 8, no. 4 (April 2009): 8. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332.
    • Vancouver/ICMJE:
      Aveo initiates Phase Ib/IIa breast cancer trial. PharmaWatch: Cancer [Internet]. 2009 Apr [cited 2020 May 30];8(4):8. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37326332